Company profile for Biocon Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilar organization. It is leveraging cutting-edge science, innovative tech platforms, and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six mol...
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilar organization. It is leveraging cutting-edge science, innovative tech platforms, and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like the United States, EU, Australia, Canada, and Japan.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
Biocon House, Semicon Park Electronics City, Phase – II, Hosur Road Bengalur...
Telephone
Telephone
+91 8067756775
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.reuters.com/business/healthcare-pharmaceuticals/indias-biocon-make-biocon-biologics-wholly-owned-subsidiary-2025-12-06/

REUTERS
06 Dec 2025

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocons-bengaluru-drug-manufacturing-facility-gets-voluntary-action-indicated-classification-by-usfda/articleshow/125603577.cms

ECONOMICTIMES
27 Nov 2025

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-in-very-unique-position-globally-as-a-biosimilars-leader-kiran-mazumdar-shaw/articleshow/125470515.cms

ECONOMICTIMES
21 Nov 2025

https://economictimes.indiatimes.com/industry/healthcare/biotech/biocon-considers-merging-biocon-biologics-in-4-5-billion-deal-ipo-and-share-swap-options-under-review/articleshow/125282919.cms

ECONOMICTIMES
13 Nov 2025

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-gets-health-canada-nod-for-biosimilars-yesintek-yesintek-iv/articleshow/124752568.cms

ECONOMICTIMES
23 Oct 2025

https://www.indianpharmapost.com/news/biocon-biologics-and-civica-launch-private-label-insulin-glargine-18031

INDPHARMAPOST
18 Oct 2025

ABOUT THIS PAGE

Contact Biocon Biologics and get a quotation

Biocon Biologics is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Insulin bulk offered by Biocon Biologics

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty